BioPolymer

BioPolymer is a privately held German medical device company focused on injectable hyaluronic-acid-based implants for orthopedic applications. The company develops and manufactures non-animal, biofermentation-derived hyaluronic acid gels, with a particular emphasis on intra-articular viscosupplementation products. Its lead marketed product, Crespine Gel, is a resorbable cross-linked hyaluronic acid implant used for pain reduction and functional improvement in degenerative joint conditions such as knee and hip osteoarthritis. BioPolymer positions its core know-how around proprietary hyaluronic acid formulation and crosslinking technologies, including ATT and CRM, designed to improve product durability, biocompatibility, and injectability. The business appears commercial-stage, distributor-driven, and export-oriented, with products available internationally from its manufacturing base in Germany.